ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
X-Chem has secured drug discovery pacts with two Japanese firms. In what X-Chem calls a transformative deal, Astellas Pharma will use X-Chem’s DNA-encoded libraries to find lead compounds against tough drug targets. X-Chem scores $16 million upfront, as well as research support and milestone payments throughout the multiyear deal. Separately, Ono Pharmaceutical has teamed with X-Chem to develop drug leads against oncology targets.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X